期刊論文1. | 林靜芳、王浴(20100700)。協助漸凍人撤除呼吸器之護理經驗:一個案報告。安寧療護,15(2),229-239。 延伸查詢 |
2. | 孫效智(20090300)。漸凍人氣切的倫理與法律問題。政治與社會哲學評論,28,177-200。 延伸查詢 |
3. | Brown, R. H.、Al-Chalabi, A.(2017)。Amyotrophic Lateral Sclerosis。New England Journal of Medicine,377(2),162-172。 |
4. | Chio, A.、Logroscino, G.、Traynor, B. J.(2013)。Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature。Neuroepidemiology,41,118-130。 |
5. | Mehta, P.、Kaye, W.、Raymond, J.(2018)。Prevalence of Amyotrophic Lateral Sclerosis--United States, 2015。Morbidity and Mortality Weekly Report,67,1285-1289。 |
6. | Worms, P. M.(2001)。The epidemiology of motor neuron diseases: a review of recent studies。J. Neurol. Sci.,191,3-9。 |
7. | Sutedja, N. A.、Veldink, J. H.、Fischer, K.(2007)。Lifetime occupation, education, smoking, and risk of ALS。Neurology,69,1508-1514。 |
8. | Rowland, L. P.、Shneider, N. A.(2001)。Amyotrophic lateral sclerosis。N. Engl. J. Med.,344,1688-1700。 |
9. | Peters, O. M.、Ghasemi, M.、Brown, R. H. Jr.(2015)。Emerging mechanisms of molecular pathology in ALS。J. Clin. Invest.,125,1767-1779。 |
10. | Schultz, J.(2018)。Disease-Modifying Treatment of Amyotrophic Lateral Sclerosis。The American Journal of Managed Care,24,327-335。 |
11. | Scott, K.、Shannon, R.、Roche-Green, A.(2016)。Pharmacologic Management Strategies in ALS #301。J. Palliat. Med.,19,335-336。 |
12. | Jenkins, T. M.、Hollinger, H.、McDermott, C. J.(2014)。The evidence for symptomatic treatments in amyotrophic lateral sclerosis。Curr. Opin. Neurol.,27,524-531。 |
13. | Ahmed, A.、Simmons, Z.(2013)。Pseudobulbar affect: prevalence and management。Therapeutics and Clinical Risk Management,9,483-489。 |
14. | Stephens, H. E.、Lehman, E.、Raheja, D.(2015)。Pain in amyotrophic lateral sclerosis: Patient and physician perspectives and practices。Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,17,21-29。 |
15. | Scott, K.、Sener, U.、Shannon, R.、Roche-Green, A.、Boylan, K.(2016)。Nonpharmacologic Management Strategies in ALS #300。J. Palliat. Med.,19,333-334。 |
16. | Heffernan, C.、Jenkinson, C.、Holmes, T.(2004)。Nutritional management in MND/ALS patients: an evidence based review。Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,5,72-83。 |
17. | Mitchell, J. D.、Borasio, G. D.(2007)。Amyotrophic lateral sclerosis。Lancet,369,2031-2041。 |
18. | Miller, Rea G.(2009)。Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology。Neurology,73,1218-1226。 |
19. | Paganoni, S.、Macklin, E. A.、Lee, A.(2014)。Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)。Amyotroph Lateral Scler Frontotemporal Degener,15,453-456。 |
20. | Danel-Brunaud, V.、Touzet, L.、Chevalier, L.(2017)。Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review。Rev. Neurol.,173,300-307。 |
21. | Rabkin, J. G.、Goetz, R.、Factor-Litvak, P.(2015)。Depression and wish to die in a multicenter cohort of ALS patients。Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,16,265-273。 |
22. | Mitsumoto, H.、Bromberg, M.、Johnston, W.(2005)。Promoting excellence in end-of-life care in ALS。Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders,6,145-154。 |
23. | Kang, S. C.、Hwang, S. J.、Wu, P. Y.、Tsai, C. P.(2013)。The utilization of hospice care among patients with motor neuron diseases: the experiences of Taiwan in 2005 to 2010。J. Chin. Med. Assoc.,76,390-394。 |
24. | Hogden, A.、Foley, G.、Henderson, R. D.、James, N.、Aoun, S. M.(2017)。Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach。J. Multidiscip. Healthc.,10,205-215。 |
25. | 呂映瑾、陳冠廷(20090300)。漸凍人呼吸器之撤除:一個案報告。安寧療護,14(1),70-79。 延伸查詢 |
26. | 林月津(2018)。運動神經元疾病(漸凍人)照護。全聯護訊,124。 延伸查詢 |
27. | 何紜緹(2013)。運動神經元疾病--漸凍人重度期的安寧出路。生命雙月刊,121。 延伸查詢 |